KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Shares Outstanding (Weighted Average) (2017 - 2025)

Historic Shares Outstanding (Weighted Average) for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $124.8 million.

  • Guardant Health's Shares Outstanding (Weighted Average) rose 142.71% to $124.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.8 million, marking a year-over-year increase of 142.71%. This contributed to the annual value of $122.7 million for FY2024, which is 960.55% up from last year.
  • Latest data reveals that Guardant Health reported Shares Outstanding (Weighted Average) of $124.8 million as of Q3 2025, which was up 142.71% from $124.1 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Shares Outstanding (Weighted Average) registered a high of $124.8 million during Q3 2025, and its lowest value of $101.0 million during Q1 2021.
  • Over the past 5 years, Guardant Health's median Shares Outstanding (Weighted Average) value was $108.8 million (recorded in 2023), while the average stood at $111.4 million.
  • As far as peak fluctuations go, Guardant Health's Shares Outstanding (Weighted Average) soared by 79.53% in 2023, and later soared by 1855.49% in 2024.
  • Quarter analysis of 5 years shows Guardant Health's Shares Outstanding (Weighted Average) stood at $101.3 million in 2021, then rose by 0.85% to $102.2 million in 2022, then grew by 9.6% to $112.0 million in 2023, then rose by 9.61% to $122.7 million in 2024, then grew by 1.68% to $124.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $124.8 million for Q3 2025, versus $124.1 million for Q2 2025 and $123.9 million for Q1 2025.